Home Podcasts Blind Spot - The Eye Doctor's Podcast
Blind Spot - The Eye Doctor's Podcast

Blind Spot - The Eye Doctor's Podcast

Zale Mednick 50 Episodes May 26, 2026

Blind Spot is a podcast for eye care specialists that challenges them to examine their own blind spots in clinical and surgical management of eye disease. Each episode features a guest expert focusing on a specific clinical diagnosis or surgical challenge in ophthalmology. The show is hosted by Toronto-based ophthalmologist Dr. Zale Mednick.

Episodes

49. ICL vs LASIK - Is Implantable Lens Surgery Better for High Prescriptions? (Dr. Avi Wallerstein) May 26, 2026 2400 Implantable collamer lenses, or ICLs, have evolved from a niche alternative for extreme prescriptions into a mainstream refractive option that is increasingly being chosen over LASIK—even for some ideal LASIK candidates. In this episode, we explore what changed: the history of the procedure, how ICL surgery is performed, the real risks and safety considerations, and how the visual outcomes compare
48. Should Intracameral Antibiotics Be Used in Cataract Surgery? (Dr. Steve Arshinoff) Apr 6, 2026 1858 The use of intracameral antibiotics - specifically intracameral moxifloxacin - has become relatively mainstream practice in cataract surgery. But how effective is it in preventing endophthalmitis? Are ophthalmologists administering it correctly?  And what are some of the potential adverse effects that can result from intracameral moxifloxacin? Leading expert in the field, Dr. Steve Arshinoff, join
Anterior Vitrectomy (Dr. Uday Devgan - The Cataract Coach) Mar 22, 2026 1777 When a posterior capsule rupture occurs during cataract surgery, the standard teaching is that we do an anterior vitrectomy if the hyaloid face is broken and vitreous comes forward. But why is the anterior vitrectomy so important? Is it always 100% necessary? And what are some tips on performing the anterior vitrectomy as safely and effectively as possible. Dr. Uday Devgan, aka The Cataract Coach,
47. Multifocal Intraocular Lenses (Dr. Elizabeth Yeu) Mar 2, 2026 2820 In this episode, Dr. Elizabeth Yeu shares her expertise on multifocal intraocular lenses (IOLs), discussing patient communication, surgical considerations, optics, and personality traits that influence candidacy. Whether you're an ophthalmologist or optometrist, gain practical tips to improve patient outcomes and satisfaction.This episode is sponsored by Thea Pharma Canada - https://www.theapharma
46. Bilateral Cataract Surgery - A Good Idea? (Dr. Steve Arshinoff) Jan 15, 2026 2188 In this episode of Blind Spot, Zale discusses the controversial topic of bilateral cataract surgery with Dr. Steve Arshinoff, a leading expert in the field. They explore the historical context, current debates, and the potential benefits and risks associated with performing cataract surgery on both eyes simultaneously. Dr. Arshinoff shares insights from his extensive research and experience, addre
45. The Essence of Invention (Dr. Kieran Murphy) Nov 18, 2025 2816 In this episode of Blind Spot, Zale sits down with Dr. Kieran Murphy, a renowned inventor and professor of radiology, to explore the essence of invention and creativity in medicine. Dr. Murphy shares his journey from medical innovations to his thoughts on the socio-economic factors that influence creativity. Discover how invention is not just about genius but a mindset, and learn about the challen
44. The ZEDS Trial - How Should We Treat Zoster? (Dr. Benny Jeng) Oct 19, 2025 2057 In this episode, Zale sits down with Dr. Benny Jeng, head of the ZEDS study which investigated the role of longer time antiviral treatmetn for patients with HZO with ocular involvement.  They review the results of the study and disuss whether long term oral antivirals reduces zoster recurrences and the severity and duration of post-herpetic neuralgia. This episode is sponsored by Thea Pharma Canad
43. Floaters - To Treat or Not to Treat? (Dr. Matthew Tenant) Sep 25, 2025 1847 In this episode, Dr. Matthew Tennant discusses the common issue of floaters in ophthalmology, exploring their physiological basis, patient experiences, and the limitations of current treatment options. The conversation delves into traditional methods like vitrectomy and YAG vitreolysis, highlighting their risks and effectiveness. Dr. Tennant also introduces PulseMedica, a startup developing innova
42. Surgical Excellence - Mental Strategies for Peak Performance (Dr. Cassidy Preston) Aug 20, 2025 2862 In this episode, Zale delves into the world of mental performance with Dr. Cassidy Preston, a renowned mental performance coach. Discover practical mental hacks and habits that can elevate your mindset and performance to enhance your surgical practice. Dr. Preston shares insights on the importance of an inside-out approach, the power of routines, and how to maintain focus and confidence in high-pr
41. Fuchs Dystrophy (Dr. Guillermo Rocha) Jun 25, 2025 3188 Fuchs Dystrophy is an important condition to be aware before operating on any patient.  Cataract surgery, in particular, can cause someone with otherwise asymptomatic Fuchs to develop debilitating corneal edema.  Then again, not everyone with Fuchs Dystrophy is destined to develop corneal swelling.  So how do we determine which patients are at increased risk of corneal decompensation?  How do we k
40. Choosing a Glaucoma Drop (Dr. Irfan Kherani) May 21, 2025 1592 With so may IOP-lowering drops on the market, it can be challenging to know which is the most appropriate drop to start a patient on for glaucoma.  How does one choose between the variety of prostaglandin analogs, beta blockers, alpha agonists and carbonic anhydrase inhibitors that are available?  When whould one choose monoterapy vs combination therapies?  How do the drops' side effect profiles i
39. Eyezirgan - How topical Ganciclovir is changing our treatment of HSV (Dr. Parwez Hossain) Apr 15, 2025 1926 With the arrival of Eyezirgan (commercial available topical ganciclovir), we now have a more readily accessible preservative-free option for treatment of HSV.  So why is Eyezirgan a potentially important new player on the market?  How does one decide between oral or topical treatments for HSV, and is there a longer-term role for antivirals in the treatment of Zoster, in addition to just HSV? Dr. P

Recommended